ClassID:

97323

C07K2319/06 - CPC Classification

Classification description:

Fusion polypeptide containing a localisation/targetting motif containing a lysosomal/endosomal localisation signal

Recent Application in this class:
#1
20250388644
2025-12-25

TARGETED THERAPEUTIC LYSOSOMAL ENZYME FUSION PROTEINS AND USES THEREOF

#2
20250304941
2025-10-02

Polypeptide Assemblies and Methods for the Production Thereof

#3
20250235530
2025-07-24

Anti COVID-19 Therapies targeting nucleocapsid and spike proteins

#4
20250206790
2025-06-26

COMPOSITIONS AND METHODS FOR DEREPRESSING RE1 SILENCING TRANSCRIPTION FACTOR TARGET GENES

#5
20250188433
2025-06-12

COMPOSITIONS AND METHODS FOR INTERNALIZING ENZYMES

#6
20250144143
2025-05-08

Virally Educated T cells

#7
20240350606
2024-10-24

VACCINE COMPOSITIONS AND METHODS FOR ENHANCED ANTIGEN-SPECIFIC VACCINATION

#8
20240342087
2024-10-17

TARGETED EXTRACELLULAR VESICLES COMPRISING MEMBRANE PROTEINS WITH ENGINEERED GLYCOSYLATION SITES

#9
20240318157
2024-09-26

Neurotensin Variants And Tagged Proteins Comprising Neurotensin Or Sortilin Propeptide

#10
20240287148
2024-08-29

ENGINEERED BIOMOLECULES FOR NUTRIENT REPROGRAMMING

#11
20240263159
2024-08-08

GENE EDITING IN PRIMARY IMMUNE CELLS USING CELL PENETRATING CRISPR-CAS SYSTEM

#12
20240247262
2024-07-25

CRISPR/CAS SYSTEM AND METHOD FOR GENOME EDITING AND MODULATING TRANSCRIPTION

#13
20240167052
2024-05-23

RNA-GUIDED NUCLEIC ACID MODIFYING ENZYMES AND METHODS OF USE THEREOF

#14
20240158464
2024-05-16

IMMUNOGENIC PEPTIDES AND THEIR USE IN TRANSPLANTATION

#15
20240082399
2024-03-14

RECOMBINANT POLYPEPTIDES FOR REGULATABLE CELLULAR LOCALIZATION

#16
20240075129
2024-03-07

SARS-CoV-2 vaccines comprising human adenovirus vectors encoding spike and nucleocapsid-ETSD immunogens

#17
20230414725
2023-12-28

COMPOSITIONS AND METHODS FOR TREATING POMPE DISEASE

#18
20230313167
2023-10-05

Polypeptide Assemblies and Methods for the Production Thereof

#19
20230302121
2023-09-28

Methods for the treatment of COVID-19 comprising administering replication-defective adenoviruses encoding the SARS-CoV-2 spike glycoprotein and modified nucleocapsid protein

#20
20230241187
2023-08-03

Lysosomal Targeting Peptides and Uses Thereof

#21
20230059411
2023-02-23

Compositions and methods for derepressing RE1 silencing transcription factor target genes

#22
20220402977
2022-12-22

SELF-ASSEMBLING VIRAL SPIKE-EABR NANOPARTICLES

#23
20220354934
2022-11-10

Lysosomal Targeting Peptides and Uses Thereof

#24
20220226503
2022-07-21

Methods for efficient delivery of therapeutic molecules in vitro and in vivo

#25
20220056088
2022-02-24

PEPTIDE DIRECTED PROTEIN KNOCKDOWN

#26
20210386844
2021-12-16

Subcutaneous Delivery of Adenovirus with Dual Targeting

#27
20210340549
2021-11-04

Nucleic acid for treating mite allergy

#28
20210340519
2021-11-04

Polypeptide Assemblies and Methods for the Production Thereof

#29
20210283245
2021-09-16

Replication-defective adenoviruses comprising nucleic acids encoding SARS-CoV-2 s glycoprotein and modified N protein comprising an endosomal targeting sequence

#30
20210180015
2021-06-17

Membrane-Receiver Complex Therapeutics

#31
20210106667
2021-04-15

VACCINE COMPOSITIONS AND METHODS FOR ENHANCED ANTIGEN-SPECIFIC VACCINATION

#32
20210069304
2021-03-11

Lysosomal Targeting Peptides and Uses Thereof

#33
20210000929
2021-01-07

COMPOSITIONS AND METHODS FOR TREATING PARKINSON'S DISEASE

#34
20200390700
2020-12-17

Targeted extracellular vesicles comprising membrane proteins with engineered glycosylation sites

#35
20200376095
2020-12-03

MANNOSE-6-PHOSPHATE BEARING PEPTIDES FUSED TO LYSOSOMAL ENZYMES

#36
20200347113
2020-11-05

EPHA3 and multi-valent targeting of tumors

#37
20200331976
2020-10-22

Multivalent Antigens Stimulating TH1 and TH2

#38
20200317746
2020-10-08

TARGETED AND MODULAR EXOSOME LOADING SYSTEM

#39
20200308581
2020-10-01

CRISPR/Cas system and method for genome editing and modulating transcription

#40
20200270331
2020-08-27

IMMUNOGENIC PEPTIDES AND THEIR USE IN TRANSPLANTATION

#41
20200224186
2020-07-16

Polypeptide assemblies and methods for the production thereof

#42
20200207834
2020-07-02

Gene transfer systems for stem cell engineering

#43
20200062813
2020-02-27

Improved Loading of EVs with Therapeutic Proteins

#44
20200046857
2020-02-13

Reporter protein fused antibodies

#45
20200017879
2020-01-16

RNA-guided nucleic acid modifying enzymes and methods of use thereof

#46
20190351050
2019-11-21

Nucleic acids for treatment of allergies

#47
20190315819
2019-10-17

Peptide directed protein knockdown

#48
20190309029
2019-10-10

Fusion protein for improving protein expression from target mRNA

#49
20190276842
2019-09-12

RNA-guided nucleic acid modifying enzymes and methods of use thereof

#50
20190225666
2019-07-25

Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof

#51
20190224282
2019-07-25

Targeted Therapeutic Proteins

#52
20190117765
2019-04-25

Lysosomal targeting of antigens employing nucleic acids encoding lysosomal membrane polypeptide/antigen chimeras

#53
20190112588
2019-04-18

COMPOSITIONS AND METHODS FOR INTERNALIZING ENZYMES

#54
20190091316
2019-03-28

Subcutaneous Delivery of Adenovirus with Dual Targeting

#55
20190062721
2019-02-28

Therapeutic fusion proteins

#56
20190002515
2019-01-03

Generation of antigen-specific TCRs

#57
20190000949
2019-01-03

Dendritic cell composition

#58
20180346927
2018-12-06

RNA-guided nucleic acid modifying enzymes and methods of use thereof

#59
20180244745
2018-08-30

EPHA3 and multi-valent targeting of tumors

#60
20180170978
2018-06-21

Modular antigen transportation molecules and uses therof

#61
20180135012
2018-05-17

MEMBRANE-RECEIVER COMPLEX THERAPEUTICS

#62
20180125949
2018-05-10

Lysosomal targeting peptides and uses thereof

#63
20180100163
2018-04-12

Nucleic acid construct

#64
20180055911
2018-03-01

Targeted therapeutic proteins

#65
20180036357
2018-02-08

Transgenic microalgae and use thereof for oral delivery of proteins

#66
20180030429
2018-02-01

Polypeptide assemblies and methods for the production thereof

#67
20180028676
2018-02-01

METHODS AND COMPOSITIONS FOR TREATMENT OF FORBES-CORI DISEASE

#68
20180009904
2018-01-11

LYSOSOMAL TARGETING AND USES THEREOF

#69
20170362279
2017-12-21

VLP WITH A FUSION PROTEIN

#70
20170355744
2017-12-14

Nucleic acids encoding targeted therapeutic lysosomal enzyme fusion proteins

#71
20170340754
2017-11-30

Efficient delivery of therapeutic molecules in vitro and in vivo

#72
20170333569
2017-11-23

Lysosomal targeting of enzymes, and uses thereof

#73
20170312351
2017-11-02

Sequence arrangements and sequences for neoepitope presentation

#74
20170247672
2017-08-31

Method for efficient delivery of therapeutic molecules in vitro and in vivo

#75
20170246263
2017-08-31

Lysosomal targeting and uses thereof

#76
20170232076
2017-08-17

Mannose-6-phosphate bearing peptides fused to lysosomal enzymes

#77
20170218022
2017-08-03

Targeted conformationally-constrained kinked endosomal disrupting peptides

#78
20170182147
2017-06-29

CD40 ligand fusion protein vaccine

#79
20170087087
2017-03-30

Targeted extracellular vesicles comprising membrane proteins with engineered glycosylation sites

#80
20170065712
2017-03-09

Lysosomal targeting of antigens employing nucleic acids encoding lysosomal membrane polypeptide/antigen chimeras

#81
20170007680
2017-01-12

Lysosomal Targeting Peptides and Uses Thereof

#82
20160297863
2016-10-13

EPHA3 And multi-valent targeting of tumors

#83
20160279208
2016-09-29

Method for suppressing spasmodic torticollis

#84
20160271245
2016-09-22

Nucleic acids for treatment of allergies

#85
20160250309
2016-09-01

COMPOSITIONS AND METHODS FOR CANCER TREATMENT

#86
20160178635
2016-06-23

Human cellular models with biosensors

#87
20160152680
2016-06-02

Targeted therapeutic proteins

#88
20160089451
2016-03-31

METHODS AND COMPOSITIONS FOR TREATMENT OF FORBES-CORI DISEASE

#89
20160039900
2016-02-11

Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof

#90
20160031965
2016-02-04

Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof

#91
20160031964
2016-02-04

Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof

#92
20160031963
2016-02-04

Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof

#93
20150283226
2015-10-08

COMPOSITIONS AND METHODS OF MODULATING AN IMMUNE RESPONSE

#94
20150274790
2015-10-01

Modular antigen transportation molecules and uses therof

#95
20150266935
2015-09-24

Peptide directed protein knockdown

#96
20150212064
2015-07-30

DEGRANULATION INDICATOR AND METHODS OF USE THEREOF

#97
20150164965
2015-06-18

Transgenic microalgae and use thereof for oral delivery of proteins

#98
20150147310
2015-05-28

TARGETED ENZYME COMPOUNDS AND USES THEREOF

#99
20150064157
2015-03-05

Lysosomal targeting peptides and uses thereof

#100
20140219983
2014-08-07

Suppression of prostate cancer using a targeted clostridial neurotoxin

#101
20140161788
2014-06-12

Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof

#102
20140147429
2014-05-29

Therapeutic fusion proteins

#103
20140056867
2014-02-27

Targeted therapeutic proteins

#104
20130295128
2013-11-07

Chimeric vaccines

#105
20130115682
2013-05-09

Fusion proteins

#106
20130115239
2013-05-09

PROSTATE CANCER DNA VACCINE

#107
20120230975
2012-09-13

Fusion proteins

#108
20120213762
2012-08-23

Lysosomal targeting peptides and uses thereof

#109
20120189610
2012-07-26

Treatment of pain

#110
20120149084
2012-06-14

Fusion proteins

#111
20120141452
2012-06-07

Targeted therapeutic proteins

#112
20120128649
2012-05-24

Modified non-cytotoxic proteases

#113
20110223147
2011-09-15

LYSOSOMAL TARGETING PEPTIDES AND USES THEREOF

#114
20110183922
2011-07-28

Peptides that enhance acetylcholinesterase expression

#115
20110171191
2011-07-14

SUPPRESSION OF NEUROENDOCRINE DISEASES

#116
20110165137
2011-07-07

Polypeptides that bind to and inhibit secretion from growth hormone secreting cells

#117
20110160135
2011-06-30

Suppression of neuroendocrine diseases

#118
20110158973
2011-06-30

SUPPRESSION OF CANCERS

#119
20110110970
2011-05-12

Chimeric vaccines

#120
20110110964
2011-05-12

Immunogenic peptides and their use in transplantation

#121
20110091437
2011-04-21

FUSION PROTEINS

#122
20110070621
2011-03-24

Multivalent clostridial toxins

#123
20110027310
2011-02-03

Compositions and Methods for Cancer Treatment

#124
20100330105
2010-12-30

Anticancer Combination Therapies

#125
20100285061
2010-11-11

DNA immunization protocols

#126
20100266541
2010-10-21

METHODS AND AGENTS FOR MODULATING AN IMMUNE RESPONSE

#127
20100098679
2010-04-22

Promotion of peroxisomal catalase function in cells

#128
20100034802
2010-02-11

TREATMENT OF PAIN

#129
20090203575
2009-08-13

TARGETED THERAPEUTIC PROTEINS

#130
20090155208
2009-06-18

Methods and agents for modulating an immune response

#131
20090048431
2009-02-19

Multivalent clostridial toxins

#132
20090035822
2009-02-05

Fusion proteins

#133
20090029467
2009-01-29

Method for targeting lysosomal enzymes

#134
20090004174
2009-01-01

Fusion proteins

#135
20080064092
2008-03-13

Fusion proteins

#136
20070280953
2007-12-06

Amyloid β gene vaccines

#137
20070264236
2007-11-15

Novel Therapeutic Fusion Proteins

#138
20070128223
2007-06-07

Methods for generating immune responses to influenza antigens with a secretable CD40L fusion protein

#139
20060275822
2006-12-07

Fluorescent indicator using fret

#140
20060251667
2006-11-09

Recombinant nucleic acid useful for inducing protective immune response against allergens

#141
20060216305
2006-09-28

Immunogenic HIV-1 multi-clade, multivalent constructs and methods of their use

#142
20060211619
2006-09-21

Multivalent Clostridial toxin derivatives and methods of their use

#143
20060141598
2006-06-29

Promotion of peroxisomal catalase function in cells

#144
20060095988
2006-05-04

Synthetic plant genes and method for preparation

#145
20060019380
2006-01-26

Genetic vaccines directed against bacterial exotoxins

#146
14695445
2019-05-21

Pharmaceutical compositions and methods of blocking